133 related articles for article (PubMed ID: 8647143)
1. Treatment of prostate cancer with transrectal focused ultrasound: early clinical experience.
Gelet A; Chapelon JY; Bouvier R; Souchon R; Pangaud C; Abdelrahim AF; Cathignol D; Dubernard JM
Eur Urol; 1996; 29(2):174-83. PubMed ID: 8647143
[TBL] [Abstract][Full Text] [Related]
2. [Preliminary results of the treatment of 44 patients with localized cancer of the prostate using transrectal focused ultrasound].
Gelet A; Chapelon JY; Bouvier R; Pangaud C; Souchon R; Blanc E; Cathignol D; Dubernard JM
Prog Urol; 1998 Feb; 8(1):68-77. PubMed ID: 9533155
[TBL] [Abstract][Full Text] [Related]
3. Local control of prostate cancer by transrectal high intensity focused ultrasound therapy: preliminary results.
Gelet A; Chapelon JY; Bouvier R; Pangaud C; Lasne Y
J Urol; 1999 Jan; 161(1):156-62. PubMed ID: 10037389
[TBL] [Abstract][Full Text] [Related]
4. Local control of prostate cancer by transrectal HIFU-therapy.
Kiel HJ; Wieland WF; Rössler W
Arch Ital Urol Androl; 2000 Dec; 72(4):313-9. PubMed ID: 11221062
[TBL] [Abstract][Full Text] [Related]
5. Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma.
Stock RG; Stone NN; DeWyngaert JK; Lavagnini P; Unger PD
Cancer; 1996 Jun; 77(11):2386-92. PubMed ID: 8635111
[TBL] [Abstract][Full Text] [Related]
6. High-intensity focused ultrasound in prostate cancer: results after 3 years.
Chaussy C; Thüroff S
Mol Urol; 2000; 4(3):179-82. PubMed ID: 11062372
[TBL] [Abstract][Full Text] [Related]
7. Results and side effects of high-intensity focused ultrasound in localized prostate cancer.
Chaussy C; Thüroff S
J Endourol; 2001 May; 15(4):437-40; discussion 447-8. PubMed ID: 11394458
[TBL] [Abstract][Full Text] [Related]
8. HIFU as salvage first-line treatment for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: a pilot study.
Asimakopoulos AD; Miano R; Virgili G; Vespasiani G; Finazzi Agrò E
Urol Oncol; 2012 Sep; 30(5):577-83. PubMed ID: 21292508
[TBL] [Abstract][Full Text] [Related]
9. [Results of transrectal focused ultrasound for the treatment of localized prostate cancer (120 patients with PSA < or + 10ng/ml].
Poissonnier L; Gelet A; Chapelon JY; Bouvier R; Rouviere O; Pangaud C; Lyonnet D; Dubernard JM
Prog Urol; 2003 Feb; 13(1):60-72. PubMed ID: 12703356
[TBL] [Abstract][Full Text] [Related]
10. Local recurrence of prostate cancer after external beam radiotherapy: early experience of salvage therapy using high-intensity focused ultrasonography.
Gelet A; Chapelon JY; Poissonnier L; Bouvier R; Rouvière O; Curiel L; Janier M; Vallancien G
Urology; 2004 Apr; 63(4):625-9. PubMed ID: 15072864
[TBL] [Abstract][Full Text] [Related]
11. High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience.
Blana A; Walter B; Rogenhofer S; Wieland WF
Urology; 2004 Feb; 63(2):297-300. PubMed ID: 14972475
[TBL] [Abstract][Full Text] [Related]
12. Control of prostate cancer by transrectal HIFU in 227 patients.
Poissonnier L; Chapelon JY; Rouvière O; Curiel L; Bouvier R; Martin X; Dubernard JM; Gelet A
Eur Urol; 2007 Feb; 51(2):381-7. PubMed ID: 16857310
[TBL] [Abstract][Full Text] [Related]
13. Evolution and outcomes of 3 MHz high intensity focused ultrasound therapy for localized prostate cancer during 15 years.
Thüroff S; Chaussy C
J Urol; 2013 Aug; 190(2):702-10. PubMed ID: 23415962
[TBL] [Abstract][Full Text] [Related]
14. Transrectal high-intensity focused ultrasound: minimally invasive therapy of localized prostate cancer.
Gelet A; Chapelon JY; Bouvier R; Rouvière O; Lasne Y; Lyonnet D; Dubernard JM
J Endourol; 2000 Aug; 14(6):519-28. PubMed ID: 10954310
[TBL] [Abstract][Full Text] [Related]
15. High-intensity focused ultrasound therapy for clinically localized prostate cancer.
Lee HM; Hong JH; Choi HY
Prostate Cancer Prostatic Dis; 2006; 9(4):439-43. PubMed ID: 16847468
[TBL] [Abstract][Full Text] [Related]
16. Transrectal high intensity focused ultrasound for the treatment of localized prostate cancer: factors influencing the outcome.
Gelet A; Chapelon JY; Bouvier R; Rouvière O; Lyonnet D; Dubernard JM
Eur Urol; 2001 Aug; 40(2):124-9. PubMed ID: 11528187
[TBL] [Abstract][Full Text] [Related]
17. New integrated imaging high intensity focused ultrasound probe for transrectal prostate cancer treatment.
Pichardo S; Gelet A; Curiel L; Chesnais S; Chapelon JY
Ultrasound Med Biol; 2008 Jul; 34(7):1105-16. PubMed ID: 18258351
[TBL] [Abstract][Full Text] [Related]
18. Results of high intensity focused ultrasound treatment of prostate cancer: early Canadian experience at a single center.
Elterman DS; Barkin J; Radomski SB; Fleshner NE; Liu B; Bensimon K; Arora S; Robinette M; Finelli A
Can J Urol; 2011 Dec; 18(6):6037-42. PubMed ID: 22166332
[TBL] [Abstract][Full Text] [Related]
19. [Role of transrectal ultrasonography in the follow-up of patients treated with prostatic cryosurgery].
Galosi AB; Muzzonigro G; Polito M; Minardi D; Dellabella M; Lugnani F; Polito M
Arch Ital Urol Androl; 2000 Dec; 72(4):276-81. PubMed ID: 11221054
[TBL] [Abstract][Full Text] [Related]
20. Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound.
Cirillo S; Petracchini M; D'Urso L; Dellamonica P; Illing R; Regge D; Muto G
BJU Int; 2008 Aug; 102(4):452-8. PubMed ID: 18476973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
